![11 September 2019, Saxony-Anhalt, Dessau-Roßlau: Philip Burchard, Managing Director of Merz Pharma GmbH & Co. KGaA, taken at the Dessau location. The globally operating company has invested 15 million euros in a 11 September 2019, Saxony-Anhalt, Dessau-Roßlau: Philip Burchard, Managing Director of Merz Pharma GmbH & Co. KGaA, taken at the Dessau location. The globally operating company has invested 15 million euros in a](https://c8.alamy.com/comp/WT8GMP/11-september-2019-saxony-anhalt-dessau-rolau-philip-burchard-managing-director-of-merz-pharma-gmbh-co-kgaa-taken-at-the-dessau-location-the-globally-operating-company-has-invested-15-million-euros-in-a-new-production-facility-for-the-manufacture-of-dermal-fillers-merz-currently-employs-around-150-people-at-its-site-in-the-biopharmapark-dessau-rolau-photo-hendrik-schmidtdpa-zentralbildzb-WT8GMP.jpg)
11 September 2019, Saxony-Anhalt, Dessau-Roßlau: Philip Burchard, Managing Director of Merz Pharma GmbH & Co. KGaA, taken at the Dessau location. The globally operating company has invested 15 million euros in a
![Merz und Teijin schließen Partnerschaft zur Vermarktung von Xeomin® (incobotulinumtoxinA) in Japan | Business Wire Merz und Teijin schließen Partnerschaft zur Vermarktung von Xeomin® (incobotulinumtoxinA) in Japan | Business Wire](https://mms.businesswire.com/media/20171012005647/de/612522/23/Merz_Logo.jpg)
Merz und Teijin schließen Partnerschaft zur Vermarktung von Xeomin® (incobotulinumtoxinA) in Japan | Business Wire
![Pie, Logo, Organization, Merz Pharma Gmbh Co Kgaa, Podiatry, Xperience, Blue, Text, Logo, Organization, Merz Pharma Gmbh Co Kgaa png | PNGWing Pie, Logo, Organization, Merz Pharma Gmbh Co Kgaa, Podiatry, Xperience, Blue, Text, Logo, Organization, Merz Pharma Gmbh Co Kgaa png | PNGWing](https://w7.pngwing.com/pngs/453/939/png-transparent-merz-pharma-hd-logo-thumbnail.png)